The pharmacokinetics ofsildenafil in patients with seriously impaired internal organ work (Child-PughClass C) give birth non been designed. A start acid of 25 mg should be consideredin patients with any degree of hepatic impairment [see DOSAGE ANDADMINISTRATION and CLINICAL PHARMACOLOGY]. The safety device and efficacy of combinations of Sildenafil citrate withother PDE5 Inhibitors, including REVATIO
